Jan 29 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA PLC - COVID-19 VACCINE RECEIVES POSITIVE OPINION IN EU

* ASTRAZENECA - ASTRAZENECA ANTICIPATES EU WILL SHORTLY APPROVE A CMA FOR ACTIVE IMMUNISATION TO BEGIN ACROSS MEMBER STATES.

* ASTRAZENECA - ANTICIPATES EU WILL SHORTLY APPROVE A CMA FOR ACTIVE IMMUNISATION TO BEGIN ACROSS MEMBER STATES.

* ASTRAZENECA -ALSO SEEKING EMERGENCY USE LISTING FROM WORLD HEALTH ORGANIZATION FOR ACCELERATED PATHWAY TO VACCINE AVAILABILITY IN LOW-INCOME COUNTRIES

* ASTRAZENECA - ADDITIONAL SAFETY, EFFICACY DATA FOR VACCINE TO CONTINUE TO ACCUMULATE FROM ONGOING CLINICAL TRIALS, EXPECTED TO BE PUBLISHED IN COMING WEEKS Source text for Eikon: Further company coverage: